×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NASDAQ:NKTR

Nektar Therapeutics SEC Filings & 10K Form

$4.03
-0.13 (-3.13%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.98
$4.26
50-Day Range
$3.17
$4.74
52-Week Range
$3.02
$19.37
Volume
24.40 million shs
Average Volume
2.59 million shs
Market Capitalization
$750.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.17

Recent Nektar Therapeutics SEC Filings

DateFilerForm TypeView
06/10/2022
8:25 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2022
8:20 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2022
8:40 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
8:38 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
8:36 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
8:35 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
8:33 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
8:32 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
8:09 AM
Nektar Therapeutics (Filer)
Form DEFA14A
04/29/2022
8:05 AM
Nektar Therapeutics (Filer)
Form DEF 14A
04/25/2022
3:40 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2022
3:44 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2021
5:44 PM
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2021
5:03 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2021
5:26 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2021
6:01 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
8:47 PM
Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
3:21 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2021
6:13 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:05 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2021
6:08 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:07 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:06 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:05 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:04 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
6:04 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
5:05 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:21 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2021
11:27 AM
Nektar Therapeutics (Filer)
Form DEF 14A
04/16/2021
5:02 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:21 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
6:07 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:06 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:05 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:04 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:03 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
6:03 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
7:05 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
7:44 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
7:43 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
7:42 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
10:31 AM
Nektar Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2021
5:10 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:00 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
4:25 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
5:06 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:53 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:52 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:51 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:50 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:49 PM
Nektar Therapeutics (Issuer)
NORTHCOTT JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
5:48 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
7:45 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2020
3:31 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
5:08 PM
Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
5:09 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:08 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:07 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:05 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:04 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
6:03 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
7:43 PM
Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:24 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2020
5:04 AM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
6:03 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
7:16 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
7:15 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4/A
09/25/2020
7:14 PM
Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/25/2020
7:13 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/25/2020
7:13 PM
EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/25/2020
7:12 PM
Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/25/2020
7:11 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/25/2020
7:10 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4/A
09/24/2020
8:40 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:39 PM
Lingnau Lutz (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:38 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:38 PM
EASTHAM KARIN (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:37 PM
Myriam Curet (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:36 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
8:35 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2020
7:59 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2020
7:58 PM
Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:19 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2020
5:18 PM
Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:41 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:40 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:39 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:38 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:37 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
3:10 PM
Nektar Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2020
3:20 PM
Nektar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
6:06 PM
GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
6:05 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:33 PM
Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:32 PM
Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:31 PM
Nektar Therapeutics (Issuer)
Thomsen Jillian B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:30 PM
Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:29 PM
Labrucherie Gil M (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
8:26 PM
Nektar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2020
5:03 PM
CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:NKTR) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.